Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Tricuspid Regurgitation: A Clinical Case-Based Review Of The Edwards Cardioband™ Tricuspid Valve Reconstruction System
Author(s): Stephan Baldus Added: 5 years ago

Intervention
Mitral and Tricuspid Therapies
Author(s): Nicolas M Van Mieghem , Philipp Lurz , Philip Raake Added: 2 years ago
This timely programme brings together leading physicians ideally placed to provide update and definitive comment on the latest developments within the Edwards mitral and tricuspid space. Programme Chair Prof Nicolas van Mieghem (Erasmus University, The Netherlands) is joined by Prof Philipp Lurz (Heart Center Leipzig, Germany) and Prof Philip Raake (Heidelberg University Hospital, Germany) as… View more

Intervention
Author(s): Maurizio Taramasso , Christelle Calen , Andrea Guidotti , et al Added: 3 years ago
The leading aetiology of tricuspid regurgitation (TR) in developed countries is functional, secondary to left side heart disease and pulmonary hypertension.1 Currently, moderate-to-severe TR affects approximately 1.6 million patients in the United States, of whom only 8,000 undergo tricuspid surgery annually;2 this results in an extremely large number of untreated patients with significant TR, a… View more

Intervention
Update on Transcatheter Options for TR Treatment
Author(s): Jonathan Curio , Ozan M Demir , Matteo Pagnesi , et al Added: 3 years ago
Tricuspid regurgitation (TR) is common, affecting 5% of the elderly population and, when its severity reaches moderate to severe, is an independent predictor of increased mortality.1–3 The pathophysiology of TR is mainly functional as it occurs in the context of pulmonary hypertension, left-sided heart disease and AF.4 These lead to deformation of the right ventricle (RV) and the right atrium (RA… View more

Vascular Disease and Surgery

Intervention
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Author(s): Magdalena Erlebach , Ruediger Lange Added: 3 years ago
Patients with multivalvular disease (MVD) can present with a variety of valve pathologies and combinations, often requiring a complex treatment strategy. Both the Euro Heart Survey and the EURObservational Research Programme Valvular Heart Disease Registry (presented at the European Society of Cardiology [ESC] 2018 meeting) demonstrated that more than one-fifth of patients with native valve… View more

Intervention
Author(s): Christian Besler , Christopher U Meduri , Philipp Lurz Added: 3 years ago
Accumulating evidence suggests that tricuspid regurgitation (TR) is independently associated with reduced long-term survival in the community and patients with ischaemic or dilated cardiomyopathy.1 Patients with moderate-to-severe TR suffer symptoms of progressive right heart failure, which are often difficult to treat with diuretic therapy. Prevalence estimates based on data from the Framingham… View more

Vascular Disease and Surgery

Intervention
Author(s): Chad A Kliger Added: 3 years ago
Mitral regurgitation (MR) is a complex disorder requiring the understanding of mitral anatomy and pathophysiology. With the increasing patient population of mitral regurgitation, both functional and degenerative types, and our desire for less invasive treatment approaches, transcatheter mitral valve therapies (TMVT) have emerged. After more than a decade of advancements, development in TMVT still… View more

Vascular Disease and Surgery

Intervention
EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
Author(s): Stephan Baldus Added: 1 year ago
Prof Stephan Baldus (University of Köln Medical Center, DE) shares insights from the TriCLASP post-market study (NCT04614402). This postmarket clinical follow up study, presented at EuroPCR 2022, assessed the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair. Discussion Points: 1. Unmet needs of patients with TR 2. Study… View more

Intervention
Author(s): Philipp Lurz , Wolfgang Rottbauer , Sam Dawkins , et al Start date: Apr 18, 2024

Intervention